Zukaria 5 mg is a Product of the Generic Asenapine Maleate
Zukaria 5 mg belongs to the generic category of Asenapine Maleate. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Zukaria 5 mg. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Asenapine Maleate and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.
*Up to 10% Discount
(Depends on pharmacy)
Zukaria 5 mg
Incepta Pharmaceuticals Ltd. · Sublingual Tablet
Asenapine Maleate
/ Piece
Description of Zukaria 5 mg
Zukaria 5 mg may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Zukaria 5 mg is provided below to help users gain a clear understanding of this medicine.
What Is Zukaria 5 mg Indications and Uses?
Asenapine is indicated for:
Schizophrenia in adults
Bipolar I disorder
Acute monotherapy for manic or mixed episodes in adults and pediatric patients 10 to 17 years of age
Adjunctive treatment to lithium or valproate in adults.
Maintenance monotherapy treatment in adults
Pharmacology (Source, Chemical and Physical Composition) Of Zukaria 5 mg
The mechanism of action of asenapine, in schizophrenia and bipolar I disorder, is unknown. It has been suggested that the efficacy of asenapine in schizophrenia could be mediated through a combination of antagonist activity at D2 and 5-HT 2A receptors.
Dosage And Administration of Zukaria 5 mg
Schizophrenia: adults:
Initial dose: 5 mg sublingually, twice daily
Recommended dose: 5 mg sublingually, twice daily
Maximum dose: 10 mg sublingually, twice daily
Schizophrenia maintenance treatment in adults.
Initial dose: 5 mg sublingually, twice daily
Recommended dose: 5-10 mg sublingually, twice daily
Maximum dose: 10 mg sublingually, twice daily
Bipolar mania in adults: acute and maintenance monotherapy.
Initial dose: 5-10 mg sublingually, twice daily
Recommended dose: 5-10 mg sublingually, twice daily
Maximum dose: 10 mg sublingually, twice daily
Bipolar mania in pediatric patients (10-17 years): monotherapy.
Initial dose: 2.5 mg sublingually, twice daily
Recommended dose: 2.5-10 mg sublingually, twice daily
Maximum dose: 10 mg sublingually, twice daily
Bipolar mania in adults: as an adjunct to lithium or valproate
Initial dose: 5 mg sublingually, twice daily
Recommended dose: 5-10 mg sublingually, twice daily
Maximum dose: 10 mg sublingually, twice daily
Sublingual tablets should not be swallowed. It should be placed under the tongue and left to dissolve completely. It will dissolve in saliva within seconds. Eating and drinking should be avoided for 10 minutes after administration.
Drug Interactions of Zukaria 5 mg
Asenapine should be used with caution in combination with:
Antihypertensive, as it may cause hypotension
Paroxetine (CYP2D6 substrate and inhibitor)
Side Effects of Zukaria 5 mg
The most common adverse reactions to asenapine are akathisia, somnolence, oral hypoesthesia, dizziness, extrapyramidal symptoms, nausea, increased appetite, fatigue, and increased weight.
Use During Pregnancy and Lactation
May cause extrapyramidal and/or withdrawal symptoms in neonates with third trimester exposure. Lactation studies have not been conducted to assess the presence of asenapine in human milk, the effects of asenapine on the breastfed infant, or the effects of asenapine on milk production.
Precautions And Warnings for Zukaria 5 mg
Caution should be exercised when asenapine is prescribed in elderly patients with dementia-related psychosis, QT prolongation, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, orthostatic hypotension, leukopenia, neutropenia, agranulocytosis, seizures, and the potential for cognitive and motor impairment.
Storage Conditions of It
Do not store above 30°C. Keep away from light and out of the reach of children.
Data Source: Data source of Indications and Usages, Pharmacology, Dosage & Administration, Drug Interactions, Side Effects, Use during Pregnancy & Lactation, Precautions & Warnings, Use in Special Populations, Therapeutic Class, and Storage Conditions is the concerned medicine company or respective organization.
Alternative Medicines
⚠ Disclaimer
The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines
N:B-All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines"
Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved
DBID
Registration ID: 176322642
Trade License: TRAD/DNCC/040904/2023
